A UK prospective cohort study in patients with symptoms suggestive of stable angina suggested that cardiac troponin predicts risk of myocardial infarction or cardiovascular death independent of cardiovascular risk factors and disease severity. The study included 4,240 patients (mean age 66 years, 33% female), coronary artery disease (CAD) was identified in 3,888 (92%) with 255 (6%) primary outcome events (myocardial infarction or cardiovascular death) during a median follow-up of 2.4 years. In patients with CAD, troponin concentrations were 2-fold higher in those with an event compared with those without (6.7 ng/L vs 3.3 ng/L). Troponin concentrations were associated with the primary outcome after adjusting for cardiovascular risk factors and CAD severity (adjusted HR: 2.3, log10 troponin). A troponin concentration >10 ng/L identified patients with a 50% increase in the risk of myocardial infarction or cardiovascular death. The findings suggest that cardiac troponin testing could help to guide the management of patients with chronic CAD, especially in higher-risk patients. Cardiac troponin has been used for risk stratification of patients with acute coronary syndromes. Source: https://www.jacc.org/
Restricting sugar intake during the first 1,000 days from conception was associated with a lower…
Incidental coronary artery calcium (CAC) identified on routine nongated chest CT scans predicts future coronary…
The burden of modifiable cardiovascular risk factors—not just the total number of risk factors—is strongly…
Higher blood levels of the gut microbiome-derived metabolite trimethylamine N-oxide (TMAO) were independently associated with…
Moderate consumption of naturally caffeinated beverages, particularly coffee, is generally associated with a lower risk…
To reduce the risk of cognitive decline and/or dementia specifically, the WHO just released updated…
This website uses cookies.